205 related articles for article (PubMed ID: 3034102)
21. The leukotriene B4 paradox: neutrophils can, but will not, respond to ligand-receptor interactions by forming leukotriene B4 or its omega-metabolites.
Haines KA; Giedd KN; Rich AM; Korchak HM; Weissmann G
Biochem J; 1987 Jan; 241(1):55-62. PubMed ID: 3032161
[TBL] [Abstract][Full Text] [Related]
22. Oxidation of leukotrienes at the omega end: demonstration of a receptor for the 20-hydroxy derivative of leukotriene B4 on human neutrophils and implications for the analysis of leukotriene receptors.
Clancy RM; Dahinden CA; Hugli TE
Proc Natl Acad Sci U S A; 1984 Sep; 81(18):5729-33. PubMed ID: 6091105
[TBL] [Abstract][Full Text] [Related]
23. A reevaluation of the chemotactic potency of leukotriene B4 (LTB4).
Jubiz W
Biochem Biophys Res Commun; 1983 Feb; 110(3):842-50. PubMed ID: 6301465
[TBL] [Abstract][Full Text] [Related]
24. Leukotriene B4 modulates phospholipid methylation and chemotaxis in human polymorphonuclear leukocytes.
Bomalaski JS; Dundee D; Brophy L; Clark MA
J Leukoc Biol; 1990 Jan; 47(1):1-12. PubMed ID: 2152937
[TBL] [Abstract][Full Text] [Related]
25. Comparison of the generation in vitro of chemotactically active LTB4 and its omega-metabolites by human neutrophils and lymphocytes/monocytes.
Rosenbach T; Czarnetzki BM
Clin Exp Immunol; 1987 Jul; 69(1):221-8. PubMed ID: 2820638
[TBL] [Abstract][Full Text] [Related]
26. Leukotriene B4 omega-oxidation by human polymorphonuclear leukocytes is inhibited by pyocyanin, a phenazine derivative produced by Pseudomonas aeruginosa.
Muller M; Sorrell TC
Infect Immun; 1992 Jun; 60(6):2536-40. PubMed ID: 1316878
[TBL] [Abstract][Full Text] [Related]
27. Pharmacologic actions of the second-generation leukotriene B4 receptor antagonist LY293111: in vitro studies.
Jackson WT; Froelich LL; Boyd RJ; Schrementi JP; Saussy DL; Schultz RM; Sawyer JS; Sofia MJ; Herron DK; Goodson T; Snyder DW; Pechous PA; Spaethe SM; Roman CR; Fleisch JH
J Pharmacol Exp Ther; 1999 Jan; 288(1):286-94. PubMed ID: 9862783
[TBL] [Abstract][Full Text] [Related]
28. In vitro and in vivo chemotaxis of guinea pig leukocytes toward leukotriene B4 and its w-oxidation products.
Czarnetzki BM; Mertensmeier R
Prostaglandins; 1985 Jul; 30(1):5-11. PubMed ID: 2996056
[TBL] [Abstract][Full Text] [Related]
29. The leukotriene B
Deng B; Lin Y; Ma S; Zheng Y; Yang X; Li B; Yu W; Xu Q; Liu T; Hao C; He R; Ding F
Kidney Int; 2017 Jul; 92(1):89-100. PubMed ID: 28318626
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of neutrophil and eosinophil induced chemotaxis by nedocromil sodium and sodium cromoglycate.
Bruijnzeel PL; Warringa RA; Kok PT; Kreukniet J
Br J Pharmacol; 1990 Apr; 99(4):798-802. PubMed ID: 2163279
[TBL] [Abstract][Full Text] [Related]
31. 6-trans-leukotriene B4 is a neutrophil chemotaxin in the guinea pig dermis.
Fretland DJ; Widomski DL; Anglin CP; Walsh RE; Levin S; Gaginella TS
J Leukoc Biol; 1991 Mar; 49(3):283-8. PubMed ID: 1847716
[TBL] [Abstract][Full Text] [Related]
32. Binding and metabolism of leukotriene B4 by neutrophils and their subcellular organelles.
O'Flaherty J; Kosfeld S; Nishihira J
J Cell Physiol; 1986 Mar; 126(3):359-70. PubMed ID: 3005343
[TBL] [Abstract][Full Text] [Related]
33. Metabolism of leukotriene B4 by activated human polymorphonuclear granulocytes.
Brom J; Schönfeld W; König W
Immunology; 1988 Jul; 64(3):509-18. PubMed ID: 2842254
[TBL] [Abstract][Full Text] [Related]
34. Neutrophil chemotaxis to leukotriene B4 in vitro is decreased for the human neonate.
Dos Santos C; Davidson D
Pediatr Res; 1993 Mar; 33(3):242-6. PubMed ID: 8384710
[TBL] [Abstract][Full Text] [Related]
35. Leukotriene B4 plays a critical role in the progression of collagen-induced arthritis.
Griffiths RJ; Pettipher ER; Koch K; Farrell CA; Breslow R; Conklyn MJ; Smith MA; Hackman BC; Wimberly DJ; Milici AJ
Proc Natl Acad Sci U S A; 1995 Jan; 92(2):517-21. PubMed ID: 7831322
[TBL] [Abstract][Full Text] [Related]
36. Comparison of leukotriene B4-induced neutrophil migration through different cellular barriers.
Casale TB; Abbas MK
Am J Physiol; 1990 Apr; 258(4 Pt 1):C639-47. PubMed ID: 2159214
[TBL] [Abstract][Full Text] [Related]
37. A simultaneous quantitation of leukotriene B4 and its omega-oxidized products by gas chromatography-mass spectrometry.
Izumi T; Shimizu T; Kasama T; Seyama Y; Sumimoto H; Takeshige K; Minakami S; Wetterholm A; Rådmark O
Biochem Biophys Res Commun; 1986 Jan; 134(2):512-8. PubMed ID: 3004451
[TBL] [Abstract][Full Text] [Related]
38. The in vitro and in vivo pharmacologic activity of the potent and selective leukotriene B4 receptor antagonist CP-105696.
Showell HJ; Pettipher ER; Cheng JB; Breslow R; Conklyn MJ; Farrell CA; Hingorani GP; Salter ED; Hackman BC; Wimberly DJ
J Pharmacol Exp Ther; 1995 Apr; 273(1):176-84. PubMed ID: 7714764
[TBL] [Abstract][Full Text] [Related]
39. Leukotriene b4 and its metabolites prime the neutrophil oxidase and induce proinflammatory activation of human pulmonary microvascular endothelial cells.
Eun JC; Moore EE; Banerjee A; Kelher MR; Khan SY; Elzi DJ; McLaughlin NJ; Silliman CC
Shock; 2011 Mar; 35(3):240-4. PubMed ID: 20926984
[TBL] [Abstract][Full Text] [Related]
40. Leukotriene B₄ Metabolism and p70S6 Kinase 1 Inhibitors: PF-4708671 but Not LY2584702 Inhibits CYP4F3A and the ω-Oxidation of Leukotriene B₄ In Vitro and In Cellulo.
Archambault AS; Turcotte C; Martin C; Lefebvre JS; Provost V; Laviolette M; Flamand N
PLoS One; 2017; 12(1):e0169804. PubMed ID: 28068410
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
